- Cat. No.
- A11708
Memantine hydrochloride
Synonyms: Namenda
Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
N-methyl-D-aspartate (NMDA) receptor antagonists and modulators act on glutamate-gated ion channels in neurons. NMDA receptors take part in excitatory synaptic transmission, synaptic plasticity and excitotoxicity. The first NMDA receptor subunit was cloned from rat brain in 1991. Extracellular magnesium blocks the channel in a voltage-dependent manner, so activation requires both agonist binding and membrane depolarization. The category includes the agonist NMDA itself, the channel blocker memantine hydrochloride and the competitive antagonist SDZ 220-581. Subunit-selective tools include TCN 201, a negative allosteric modulator of GluN2A-containing receptors, and GNE 0723, a positive allosteric modulator of the same receptors.
Synonyms: Namenda
Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
Synonyms: Lanicemine hydrochloride; AR-R15896AR
ARL-15896 is a novel N-methyl-D-aspartate receptor ion channel antagonist.
Synonyms: D 9998
Non-opioid analgesic with muscle relaxant properties.
Synonyms: Norflex
Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
Synonyms: NSC13123
Creatinine acts as a GABAA and NMDA receptor modulator, demonstrating antioxidant properties and metabolic regulation. It is produced through the non-enzymatic conversion of creatine and phosphocreatine in muscle, making its serum levels an important biomarker for renal function, muscle mass, and clinical outcomes. Creatinine is utilized in evaluating perioperative renal risk and has applications in research on neurodegenerative diseases, psychiatric disorders, acute and chronic kidney injury, and renal failure. Additionally, it can induce specific Cryptococcus species to produce creatinine deiminase, highlighting its role in metabolic studies.
Synonyms: Felbatol
Felbamate is an antagonist at the NMDA-associated glycine binding site.
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
SDZ 220-581 is a competitive NMDA receptor antagonist (pKi = 7.7).
GNE 0723 is a brain permeable positive allosteric modulator of NMDAR, with an EC50 of 21 nM for GluN2A, 7.4 and 6.2 μM for GluN2C and GluN2D, respectively.
Synonyms: Dizocilpine maleate; Dizocilpine hydrogen maleate; MK 801; Dizocilpine
(+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
Synonyms: SL-820715
Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
RPR104632 is a specific antagonist of NMDA receptor, with potent neuroprotective properties.
Synonyms: MK801
(-)-MK 801 maleate acts as a potent, selective, and non-competitive NMDA receptor antagonist. It acts by binding to a site located within the NMDA associated ion channel.
GV-196771A is the sodium salt form of GV196771, is an NMDA receptor antagonist.
Synonyms: GLYX 13
GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor which is under development by Naurex as adjunctive therapy for treatment-resistant depression.
MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
DNQX is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
Memantine is a noncompetitive antagonist of the N-methyl-D-aspartate receptor (NMDAR). It has been shown to modulate excitotoxicity and is utilized in research studies focused on moderate-to-severe Alzheimer's disease (AD). This compound is essential for exploring pathways related to neurodegeneration and cognitive function.
Synonyms: NVP,PEAQX; PEAQX
NVP-AAM077 inhibited progenitor cells proliferation in the subventricular zone and dentate gyrus and reduced the survival of newborn cells in the dentate gyrus in the adult mice.
SDZ 220-581 ammonium salt is a potent, competitive antagonist at the NMDA glutamate receptor subtype(pKi= 7.7).
L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,
CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.
CGS 19755 (cis-4-phosphonomethyl-2-piperidine carboxylic acid) was found to be a potent, stereospecific inhibitor of N-methyl-D-aspartate (NMDA)-evoked, but not KCl-evoked, [3H] acetylcholine release from slices of the rat striatum.
Synonyms: FG-9065
CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors, respectively, versus IC50 = 25 uM for NMDA receptors).
Ifenprodil tartrate is the atypical N-methyl-D-aspartate (NMDA) receptor antagonist, inhibits NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).